Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joaquín Fuentes
Observed names:
J. Fuentes,
Joaquin Fuentes
Institution:
Policlínica Gipuzkoa
Observed institutions:
Hospital Son Llatzer,
Eli Lilly (United Kingdom),
Policlínica Gipuzkoa,
Basildon Hospital,
Universitat de les Illes Balears,
KU Leuven
show all 6
ORCID:
0000-0001-5488-5543
Observed ORCID:
0000-0001-5488-5543
OpenAlex ID:
A5029534973
Impact of war and forced displacement on children’s mental health—multilevel, needs-oriented, and trauma-informed approaches
2022
·
David Bürgin
, Dimitris Anagnostopoulos
, et al.
·
European Child & Adolescent Psychiatry
·
420
PDF
Tackling healthcare access barriers for individuals with autism from diagnosis to adulthood
2021
·
Natasha Malik-Soni
, Andrew Shaker
, et al.
·
Pediatric Research
·
387
PDF
ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment
2020
·
Joaquin Fuentes
, Amaia Hervás
, et al.
·
European Child & Adolescent Psychiatry
·
247
PDF
Use of early intervention for young children with autism spectrum disorder across Europe
2015
·
Erica Salomone
, Štěpánka Beranová
, et al.
·
Autism
·
145
The ASDEU autism prevalence study in northern Spain
2020
·
Joaquin Fuentes
, Ane Basurko
, et al.
·
European Child & Adolescent Psychiatry
·
49
Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder
2009
·
Rodrigo Escobar
, Alonso Montoya
, et al.
·
Journal of Child and Adolescent Psychopharmacology
·
49
Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies
2023
·
Joaquin Fuentes
, Mara Parellada
, et al.
·
Autism Research
·
47
PDF
Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders
2021
·
Carmen M. Schroder
, Tobias Banaschewski
, et al.
·
Expert Opinion on Pharmacotherapy
·
45
PDF
Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
2020
·
Véronique Crutel
, Estelle Lambert
, et al.
·
Journal of Autism and Developmental Disorders
·
32
PDF
Evaluating internet information on attention-deficit/hyperactivity disorder (ADHD) treatment: Parent and expert perspectives
2013
·
Alonso Montoya
, Sergio Hernández
, et al.
·
Education for Health
·
27
Long-Term Quality-of-Life and Functioning Comparison of Atomoxetine Versus Other Standard Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder
2013
·
Joaquin Fuentes
, Marina Danckaerts
, et al.
·
Journal of Clinical Psychopharmacology
·
22
Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder
2014
·
Alonso Montoya
, Esther Cardo
, et al.
·
Neuropsychiatric Disease and Treatment
·
20
PDF
Bioethical Issues in Neuropsychiatric Genetic Disorders
2007
·
Joaquin Fuentes
, M. Concepción Martín-Arribas
·
Child and Adolescent Psychiatric Clinics of North America
·
19
Against Le Packing: A Consensus Statement
2011
·
David Amaral
, Sally J. Rogers
, et al.
·
Journal of the American Academy of Child & Adolescent Psychiatry
·
18
Practice Tools for Screening and Monitoring Insomnia in Children and Adolescents with Autism Spectrum Disorder
2021
·
Tobias Banaschewski
, Oliviero Bruni
, et al.
·
Journal of Autism and Developmental Disorders
·
17
PDF
Brief Report: Antibodies Reacting to Brain Tissue in Basque Spanish Children with Autism Spectrum Disorder and Their Mothers
2013
·
Christy C. Rossi
, Joaquin Fuentes
, et al.
·
Journal of Autism and Developmental Disorders
·
17
El Cuestionario de Capacidades y Dificultades
2000
·
Presentación Ángeles Caballero García
, Ronald W. Goodman
, et al.
·
Revista de Psiquiatría Infanto-Juvenil
·
16
PDF
A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics
2022
·
Christina Georgoula
, Maite Ferrin
, et al.
·
Child Psychiatry & Human Development
·
15
Challenges to the Human Rights of People with Intellectual Disabilities
2010
·
Joaquin Fuentes
·
Journal of Applied Research in Intellectual Disabilities
·
14
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
2021
·
Véronique Crutel
, Estelle Lambert
, et al.
·
Journal of Autism and Developmental Disorders
·
11
PDF
The past decade
2006
·
Gary B. Mesibov
, Joaquin Fuentes
, et al.
·
Autism
·
9
Autism Spectrum Disorders: Ten Tips to Support Me
2014
·
Joaquin Fuentes
·
Journal of the American Academy of Child & Adolescent Psychiatry
·
5
Applying TEACCH in Developing Autism Services in Spain: The GAUTENA Project
2000
·
Joaquin Fuentes
, Ramon Barinaga
, et al.
·
International Journal of Mental Health
·
5
Fast vs. Slow Switching from Stimulants to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
2013
·
Esther Cardo
, Vibeke Porsdal
, et al.
·
Journal of Child and Adolescent Psychopharmacology
·
4
Partnering for the World's Children
2015
·
Paramjit T. Joshi
, Bennett L. Leventhal
, et al.
·
Child and Adolescent Psychiatric Clinics of North America
·
2
Show more works
View as search
Works count:
46
Citation count:
1,644
H-index:
16
I10-index:
20
Year
Topic
Type
